Abcam Introduces Exclusive Range of Highly Validated Antibody Conjugates
Abcam
03/09/2014Cambridge, UK, September 3, 2014: Abcam plc, a leading provider of protein research tools and services, announced today it has launched an exclusive range of highly validated conjugated antibodies for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting.Abcam’s conjugated antibodies enable scientists to easily perform multi-protein analysis. It is essential for scientists to study and image proteins in their...